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INTRODUCTION
Contrast-induced nephropathy (CIN) is the acute 
impairment of renal function caused by the injection of 
iodinated contrast agents [1,2]. It is the major cause of 
iatrogenic renal failure during hospitalization. In most 
patients with CIN, there is a mild and transient decrease 
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Objective: To investigate imaging biomarkers of microperfusion in contrast-induced nephropathy (CIN) using contrast-
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Materials and Methods: The CIN model was fabricated by administering indomethacin (10 mg/kg), L-NAME (15 mg/kg), and 
iopamidol (10 mL/kg) to Sprague-Dawley rats. After 24 hours, CEUS was performed on CIN (n = 6) and control (n = 6) rats 
with sulphur hexafluoride microbubbles (SonoVue). From time-intensity curves obtained from the kidney arriving time 
(AT), acceleration time (AC), time to peak (TTP), and peak enhancement (PE) were measured and compared between the 
groups. After CEUS, the rats were sacrificed, and cell apoptosis markers were evaluated to confirm the development of CIN.
Results: Among CEUS parameters, AT (7.8 ± 1.6 vs. 4.2 ± 0.5 s, p = 0.002), AC (4.7 ± 1.4 vs. 2.0 ± 0.4 s, p = 0.002), and 
TTP (12.5 ± 2.9 vs. 6.2 ± 0.6 s, p = 0.002) were significantly prolonged in the CIN group compared to controls. PE was 
significantly higher in the control group than in the CIN group (17.1 ± 1.9 vs. 12.2 ± 2.0 dB, p = 0.004). In kidney tissue, 
mRNA and protein levels of the apoptotic makers were significantly higher in the CIN group than in the control group (p = 
0.003 and p = 0.002).
Conclusion: CEUS parameters can be used as imaging biomarkers for microperfusion in CIN. In rats with CIN, AT, AC, and TTP 
were significantly prolonged, while PE was significantly lower compared to controls.
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in renal function. However, although rare, CIN can 
cause serious chronic renal dysfunction requiring renal 
replacement therapy [3-7]. Moreover, it is known to increase 
the duration of hospital stay and long-term morbidity 
and mortality, particularly in patients with pre-existing 
chronic renal dysfunction or diabetes [3-6]. Therefore, 
there is growing interest in finding ways to reduce CIN by 
understanding its pathophysiology and developing relevant 
biomarkers.
Although the pathophysiology of CIN is complex and 
has not been clearly understood, hemodynamic changes, 
including renal vasoconstriction, are thought to be the 
primary factors contributing to CIN [8,9]. Prolonged renal 
vasoconstriction results in decreased renal blood flow 
and glomerular filtration rate [1,8]. Considering these 
hemodynamic alterations, several studies have shown that 
the magnetic resonance imaging (MRI) techniques that 
reflect tissue perfusion, such as intravoxel incoherent 
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motion (IVIM) or arterial spin labeling (ASL), might be 
useful for understanding the pathophysiology of CIN 
[10,11]. However, the clinical application of functional 
MRI, including IVIM, is limited because of the lack of 
standardized sequences, post-processing software, and 
limited accessibility.
Contrast-enhanced ultrasound (CEUS) enables continuous 
real-time imaging of vascular perfusion [12-14]. Ultrasound 
contrast agents are composed of gas microbubbles 
surrounded by a shell [13, 15]. As the rheology and 
size of these contrast agents are similar to those of red 
blood cells, they can function as red blood cell tracers, 
allowing for perfusion analyses in various organs [16, 17]. 
Moreover, CEUS has the advantages of wide accessibility, 
renal safety of contrast agents, high tolerance, and lack 
of radiation exposure [18]. The quantification of renal 
perfusion using CEUS could be valuable for understanding 
the pathophysiology underlying renal disease processes, 
including CIN, because decreased renal perfusion usually 
precedes the impairment of renal function [19]. However, 
to our knowledge, there have been no reports using 
CEUS to evaluate CIN. Therefore, this study was aimed at 
investigating potential imaging biomarkers of microperfusion 
in CIN using CEUS in an animal model.
MATERIALS AND METHODS
Animal Experiments
Twelve male Sprague-Dawley rats (OrientBio), 
approximately 1–2 months old and weighing 220–250 g, that 
had been housed in an animal laboratory were used. All 
experimental procedures were approved by the Department 
of Laboratory Animal Resources and Ethical Committee 
for animal studies. All animals were housed in a plastic 
cage while being allowed access to food and water and 
maintained in a 12-hours light and 12-hours dark cycle 
with 50 ± 100% humidity and 22°C ± 2°C temperature 
before the experiment. The CIN model was developed after 
16–24-hours water restriction, followed by intraperitoneal 
injections of 10 mg/kg indomethacin (Sigma-Aldrich) and 
15 mg/kg L-NAME (Cayman Chemical). After 15 minutes, 
10 mL/kg iopamidol (Pamiray 370, Dongkuk Pharm.) was 
injected intravenously. In addition to contrast agents, 
pretreatment with indomethacin and L-NAME, which inhibit 
vasodilatation, has been recommended to develop a reliable 
CIN rat model [20,21]. Rats were housed again with free 
access to water. After 24 hours, CEUS was performed. 
Finally, rats were euthanized, and blood and kidney tissues 
were harvested. To confirm the development of CIN, serum 
creatinine and blood urea nitrogen were measured using the 
Cobas C502 (Roche) chemistry analyzer. 
Contrast-Enhanced Ultrasound 
CIN (n = 6) and control (n = 6) rats underwent CEUS 
using an ultrasound scanner (Logiq E9, GE Healthcare) 
with a 12.5-MHz linear probe. During US examinations, rats 
were anesthetized with a mixture of tiletamine-zolazepam 
(Zoletil 50, Virbac Laboratories; 30 mg/kg) and xylazine 
(Rompun, Bayer Korea; 10 mg/kg), administered as an 
intraperitoneal injection. Before the contrast injection, 
native B-mode imaging was performed for both kidneys 
to select the kidney with a better sonic window for CEUS. 
Subsequently, rats were injected with 0.6 mL of sulphur 
hexafluoride microbubbles (SonoVue; Bracco SpA) in the 
tail vein using an infusion pump (Terufusion, Terumo) at 
a rate of 5 mL/min. Renal CEUS was performed with a low 
mechanical index (0.08), and CEUS scans were acquired 
for 5 minutes after the contrast injection (Fig. 1). Scans 
were analyzed using software (QLAB, Philips Healthcare) 
dedicated for CEUS analyses. Two board-certified abdominal 
radiologists independently performed the CEUS analysis 
to calculate the interobserver agreement. After more than 
1 month, a radiologist analyzed the CEUS scans again 
to calculate the intra-observer agreement. Three regions 
of interest (ROIs) were manually drawn in the kidney to 
include the cortex and outer medulla, and a time-intensity 
curve (TIC) was obtained (Fig. 1). TIC parameters, including 
the arriving time (AT), acceleration time (AC), time to peak 
(TTP), and peak enhancement (PE), were measured, and 
the mean value of the three ROIs was compared between 
the two groups. Each parameter was defined as follows 
(Fig. 2): AT, interval from the contrast injection to the 
beginning of enhancement; AC, interval from the beginning 
of enhancement to PE; TTP, interval from the contrast 
injection to PE; and PE, maximal signal intensity measured 
in the selected ROI.
Histological Examination and Immunohistochemistry
of the Kidneys
Kidney specimens were fixed in 10% neutral buffered 
formalin (Biosesang) for 24 hours, and paraffin blocks 
were made according to the previously published 
standard methods [22]. Paraffin blocks were then cut 
into 4-μm sections, and paraffin-embedded tissues were 
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de-paraffinized by changes in xylene and rehydrated 
in decreasing concentrations of ethanol (100%, 95%, 
80%, and 70%). The sections were then stained with 
hematoxylin and eosin (Gill III, Merck) using an automatic 
strainer (Leica). For the immunohistochemistry staining of 
cleaved caspase-3, paraffin block sections were immersed 
in methanol (Duksan) with 0.3% H2O2 for 10 minutes 
at room temperature to quench endogenous peroxidase 
activity. Subsequently, they were washed twice with Tris-
buffered saline and blocked with 5% bovine serum albumin 
in phosphate-buffered saline. After adding the cleaved 
caspase-3 antibody (1:1000 dilution, #9664, Cell Signaling 
Technologies) as the primary antibody for 1 hour at room 
temperature, they were washed twice with Tris-buffered 
saline and supplied with biotinylated goat-anti-rabbit IgG-
HRP (1:10000 dilution, #K4003 from DAKO, Glostrup) as the 
secondary antibody. The stained slides were observed with 
fluorescent microscopy (IX71/DP71, Olympus). 
Transmission Electron Microscopy
The kidney tissue morphology was examined with 
transmission electron microscopy (TEM). The tissues 
were fixed overnight in 0.1 M phosphate buffer (pH 7.4) 
containing 2% glutaraldehyde, 2% paraformaldehyde, and 
0.5% CaCl2. The samples were washed twice with 0.1 M 
phosphate buffer for 30 minutes and then fixed for 2 hours 
with 1% OSO4 dissolved in 0.1 M phosphate buffer, followed 
by dehydration through a series of ethanol concentrations 
(50–100% with increments of 10%), allocating 10 minutes 
for each concentration. Specimens were embedded with the 
Poly/Bed812 kit (Polysciences, Inc.) and polymerized at 
65°C in an electron micro-oven (TD-700, DOSAKA) for 24 
hours. The block was cut using an ultramicrotome (LEICA 
EM UC-7, Leica Microsystem) and observed with TEM (JEM-
1011, JEOL) at an acceleration voltage of 80 kV [23]. 
RNA Extraction and Quantitative Real-Time Polymerase 
Chain Reaction
Total RNA was isolated with a commercial kit (Hybrid-R 
kit 305-101, GeneAll Biotechnology), and 1 µg of total RNA 
was reverse transcribed with the amfiRivert cDNA synthesis 
kit (GenDEPOT) according to the manufacturer’s instructions. 
The expression levels of Bax, Bcl-2, neutrophil gelatinase-
Fig. 1. Renal contrast-enhanced ultrasound in a rat model. 
A. B-mode imaging (right) and contrast-enhanced imaging (left) after the contrast injection. B. A region of interest (blue line) was placed in the 















Fig. 2. Diagram of parameters according to the time-intensity 
curve. AC = acceleration time, AT = arriving time, PE = peak 




associated lipocalin (NGAL), and interleukin 18 (IL-18) were 
determined with real-time polymerase chain reaction (RT-PCR) 
using the SYBR-Green reagent (GenDEPOT) and normalized 
to β-actin. Bax and Bcl-2 are apoptosis-related genes, 
while NGAL and IL-18 are biomarkers of acute kidney injury 
[24,25]. For Bax/Bcl2 expression levels, the relative ratio 
(Bax/β-actin)/(Bcl2/β-actin) was calculated by dividing the 
separately calculated ratio (Bax/β-actin) by (Bcl2/β-actin). 
All PCR reactions were conducted in duplicate, and threshold 
cycle (Ct) values were analyzed with the 2-ΔΔCt methods. 
Western Blot Analysis 
The Western blot analysis was performed using the 
previously described method [23]. In summary, kidney 
tissue was homogenized and lysed in a pro-prep extraction 
solution (iNtRON Biotechnologist), followed by protein 
quantitation with the Bradford method. Lysates were 
fractioned on 15% sodium dodecyl sulfate-polyacrylamide 
gels and transferred to polyvinylidene difluoride membranes. 
The membrane was incubated overnight at 4°C with 
primary antibodies against Bax 1:1000 dilution, #2772 
(Cell Signaling Technologies), Bcl-2 1:1000 dilution, 
#ab59348 (Abcam), and β-actin 1:10000 dilution, #LF-
PA0207 (AbFrontier), used as the loading controls. After the 
membrane was washed thrice in 1X Tris-Buffered Saline with 
Tween (TBS-T) for 15 minutes each, it was incubated with 
the HRP-conjugated secondary antibodies (goat anti-rabbit 
IgG-HRP, 1:10000 dilution, #SA002-500 from GenDepot) for 
1 hour at room temperature. Subsequently, the membrane 
was washed thrice in 1X TBS-T for 15 minutes again. 
The blotted membrane was visualized with enhanced 
chemiluminescence reagents (GenDEPOT) and exposed to 
an X-ray film. The results were normalized to the β-actin 
loading control, and band density was measured using Image 
J software (NIH; online at https://imagej.nih.gov/ij/).
Statistical Analysis
All results are expressed as mean ± standard deviation. 
The mean values of the rat body weight, kidney function 
analysis, CEUS data, and histopathological parameters were 
compared between the control and CIN groups using the 
non-parametric Mann-Whitney U test. The inter- and intra-
observer agreements for CEUS parameters were calculated 
using the intraclass correlation coefficients (ICCs). ICC 
values ≥ 0.75, 0.60–0.74, 0.40–0.59, and < 0.40 represent 
excellent, good, fair, and poor agreements, respectively. 
Correlations between serum creatinine and CEUS parameters 
were evaluated by Spearman’s rank correlation analysis. 
Statistical analyses were performed using Prism 8.3.0 
(Graphpad) and SPSS v25.0 software (IBM Corp.). All p 
values were two-sided, and p values < 0.05 were considered 
statistically significant.
RESULTS
Kidney Function Analysis 
There was no statistical difference in the rat body weight 
between the control (292.9 ± 13.4 g) and CIN (295.4 ± 
24.2 g; p = 0.818) groups. The levels of blood urea nitrogen 
(13.5 ± 2.0 vs. 171.2 ± 45.4 mg/dL, p = 0.002) and 
creatinine (0.3 ± 0.0 vs. 1.6 ± 0.5 mg/dL, p = 0.002) were 
higher in the CIN group than in the control group.
CEUS Parameters
Table 1 summarizes the parameters of renal perfusion, 
and Figure 3 shows the representative TICs of both groups. 
AT and AC were significantly prolonged in the CIN group 
than in the control group (7.8 ± 1.6 vs. 4.2 ± 0.5 s, p = 
0.002 for AT; and 4.7 ± 1.4 vs. 2.0 ± 0.4 s, p = 0.002 for 
AC). TTP also significantly increased in the CIN group (12.5 
± 2.9 s) than in the control group (6.2 ± 0.6 s, p = 0.002). 
PE was significantly higher in the control group than in the 
CIN group (17.1 ± 1.9 vs. 12.2 ± 2.0 dB, p = 0.004). For the 
CEUS analysis, the inter-observer agreement was good to 
excellent (ICC, 0.726–0.991), and intra-observer agreement 
was excellent (ICC, 0.902–0.995) (Table 2).
All CEUS parameters significantly correlated with serum 
creatinine levels. AT (ρ = 0.886, p < 0.001), AC (ρ = 0.829, 
p = 0.001), and TTP (ρ = 0.850, p < 0.001) positively 
correlated with serum creatinine, whereas PE negatively 
correlated with serum creatinine (ρ = -0.722, p = 0.008). 
Histological Morphology of the Kidneys
Figure 4 shows the histological findings of the control 
and CIN groups. With the hematoxylin and eosin staining, 
there was no obvious change in the tubule and glomerulus 
Table 1. Contrast-Enhanced Ultrasound Parameters
Parameters Control (n = 6) CIN (n = 6) P
AT (sec)   4.2 ± 0.5   7.8 ± 1.6 0.002
AC (sec)   2.0 ± 0.4   4.7 ± 1.4 0.002
TTP (sec)   6.2 ± 0.6 12.5 ± 2.9 0.002
PE (dB) 17.1 ± 1.9 12.2 ± 2.0 0.004
AC = acceleration time, AT = arriving time, CIN = contrast-induced 
nephropathy, PE = peak enhancement, TTP = time to peak  
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between the two groups (Fig. 4). With TEM, there were more 
cytoplasmic vacuoles and greater mitochondrial expansion 
in the tubular cells of the CIN group than in the control 
group (Fig. 4). Immunohistochemistry staining for cleaved 
caspase-3 showed apoptotic cells in the CIN group (Fig. 5). 
Gene Expression of Kidney Injury Markers 
To investigate the expression of kidney injury markers, the 
mRNA expression levels of NGAL and IL-18 were compared 
between the control and CIN groups with RT-PCR. The 
expression levels of NGAL and IL-18 significantly increased 
in the CIN group compared to controls (p < 0.001 and p = 
0.003, respectively) (Table 3, Fig. 6). 
Apoptosis-Related Gene Expression 
To determine the exposure effect of contrast agents 
on apoptosis, mRNA and protein expression levels of the 
apoptosis markers (Bax, Bcl-2) were assessed. The expression 
levels of mRNA and protein (Bax/Bcl-2) significantly 
increased in the CIN group compared to controls (p = 0.003 
and p = 0.002, respectively) (Table 3, Fig. 7). 
DISCUSSION
This study showed that hemodynamic alterations in CIN 
were evident on CEUS performed 24 hours after a contrast 
agent was injected. CEUS parameters, including AT, AC, 
and TTP, increased significantly in the CIN group compared 
to controls, whereas PE was significantly lower in the 
CIN group compared to controls. In addition, all CEUS 
parameters evaluated in our study revealed significant 
correlation with serum creatinine. This result indicates 
Fig. 3. TICs in control (A) and CIN models (B). TIC in the CIN model (B) shows prolonged arriving time, acceleration time, and time to peak 
compared to the TIC in the control model (A). Peak enhancement is slightly higher in the control model (A) than in the CIN model (B). CIN = 



















Table 2. Inter-Observer and Intra-Observer Agreements for Contrast-Enhanced Ultrasound Analysis
Parameters Inter-Observer 95% CI Intra-Observer 95% CI
AT (sec) 0.991 0.967–0.997 0.995 0.983–0.999
AC (sec) 0.772 0.208–0.934 0.974 0.909–0.992
TTP (sec) 0.955 0.843–0.987 0.992 0.972–0.998
PE (dB) 0.726 0.048–0.921 0.902 0.659–0.972




that changes in CEUS parameters may reflect clinical renal 
dysfunction in CIN.
Although the pathophysiology of CIN is not well 
established, changes in vascular dynamics are a primary 
cause of acute tubular necrosis in CIN [8]. Prolonged renal 
vascular constriction results in increased renal vascular 
resistance, decreased renal blood flow, and decreased 
glomerular filtration rate, which make the outer medulla 
susceptible to necrosis [1,26]. Several imaging modalities 
have been used to evaluate renal vascular perfusion. CEUS is 
a competing technique that enables noninvasive and real-
time assessment of perfusion [13,27]. Several studies have 
reported that CEUS can be used to evaluate renal perfusion 
in various diseases, including experimental renal hypoxia, 
microvascular perfusion dysfunction in diabetic Goto-
Kakizaki rats, and renal transplant dysfunction [14,16,28-
30]. Most studies on renal hypoxia or acute congestion 
showed increased TTP or mean transit time and decreased 
PE, which indicate decreased renal flow velocity and blood 
volume, respectively [16,28,30]. Our study revealed similar 
changes in CEUS parameters as those previous studies.
Regarding other imaging modalities, functional MRI, such 
as IVIM or ASL, without administering contrast agents can 
also be used to evaluate renal perfusion [10,11,31,32]. 
A few studies have shown IVIM and ASL to be effective 
methods for monitoring the progression of CIN [10,11]. 
According to a previous study, renal blood flow measured 
with ASL significantly decreased in both the renal cortex 
and medulla in early stages of CIN (12–48 hours) [11]. 
Perfusion-related IVIM parameters, including perfusion 
fraction (f) and pseudo-diffusion coefficient (D*), also 
significantly decreased in the CIN model. In addition, there 
Fig. 4. Renal histological morphology in the control and CIN models. 
A. Histological examination of kidney tissue with hematoxylin and eosin staining. There is no obvious change in tubular cells of the glomerulus 
in the CIN group compared to the control. Magnification = x 20, scale bar = 50 μm. B. Analysis of morphology changes in the kidney using 
transmission electron microscopy. In the CIN model, more vacuoles and greater mitochondrial expansion are observed. Magnification = x 8000, 
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was a strong correlation between perfusions measured with 
ASL and IVIM in the renal cortex. Interestingly, decreases 
in D* were observed before decreases in f along time, 
which suggests that vasoconstriction might have occurred 
earlier than the decrease in fluid volume [11]. These MRI 
results are concordant with our results, although we did not 
investigate the serial changes in CEUS parameters in our 
study. 
The histopathological examination revealed significantly 
increased kidney injury markers (NGAL, IL-18) and cell 
apoptosis markers (Bax/Bcl2, cleaved caspase-3) and 
correlated with morphological changes on TEM in our 
animal model. Serum creatinine, which is elevated for 
1–3 days after the administration of contrast media, is 







mRNA expression level (AU)
NGAL 1 109.6 ± 94.6 < 0.001
IL-18 1   4.5 ± 3.6    0.003
Bax/Bcl2 1   1.8 ± 0.8    0.003
Protein expression level (AU)
Bax/Bcl2 1 10.6 ± 4.9    0.002
AU = arbitrary unit, CIN = contrast-induced nephropathy, IL-18 = 
interleukin 18, NGAL = neutrophil gelatinase-associated lipocalin  
Fig. 6. mRNA expression levels of kidney injury markers (A: 
NGAL, B: IL-18 level). Statistical significance: *p < 0.01, †p < 
0.001 between the control and CIN groups. CIN = contrast-induced 



































































Fig. 5. Immunohistochemistry of cleaved caspase-3. Arrowheads indicate stained apoptotic cells in the CIN model. Magnification = x 40, 





currently used as the diagnostic criterion for CIN. To date, 
early biomarkers of CIN, such as NGAL, cystatin C, kidney 
molecule-1, and IL-18, have been introduced, which are 
elevated only for a few hours after CIN develops [33,34]. In 
our study, the CIN group showed elevated serum creatinine 
and early biomarkers, including NGAL and IL-18, compared 
to the control group, which confirmed that the CIN model 
was well established. In addition, NGAL and IL-18 increased 
when ischemic injury occurred in the kidneys [33,34]. In 
our study, changes in CEUS parameters in the CIN group 
suggested delayed and decreased hemodynamic flow into 
the kidneys, which may have caused ischemic stress in 
the renal tissue and increased NGAL and IL-18 expression. 
However, as we did not evaluate a direct correlation 
between biomarkers and renal hemodynamic changes in this 
study, further studies are warranted.
This study had several limitations. First, the number of 
rats was small in the CIN and control groups. Second, the 
baseline CEUS parameters in CIN rats were not assessed 
before CIN development. Third, we performed the TIC analysis 
in the renal cortex and outer medulla. Although several 
previous studies on renal CEUS obtained TIC parameters 
from the cortex and medulla separately [14,16,30], reliable 
ROI placement in the medulla was challenging because 
the medullary outline was difficult to define in most rats. 
Finally, the scan planes of CEUS and histopathological slides 
may not have exactly matched, and they were assumed to be 
representative of the whole kidney. 
In conclusion, CEUS could be an effective imaging 
modality for evaluating CIN with the quantitative analysis 
of renal perfusion. In rats with CIN, AT, AC, and TTP were 
prolonged, whereas PE decreased, probably because of 
vasoconstriction, reflecting the hemodynamic changes 
in CIN. Further clinical studies with human subjects are 
required to use CEUS parameters as biomarkers for CIN 
pathophysiology and to develop prevention strategies for 
CIN.
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Fig. 7. mRNA (A) and protein (B) expression levels of the apoptotic markers (Bax/Bcl-2). Statistical significance: *p < 0.01 between 
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